Page properties |
---|
Status | In progress |
---|
Version | 0.5 |
---|
|
Descriptions:
Term | description type | Language/acceptability | Langauge/acceptability | Case significance |
---|
Adverse [finding site] reaction to [agent] (disorder) | FSN | us:P | gb:P | ci |
Adverse [finding site] reaction to [agent] | SYN | us:P | gb:P | ci |
...
The following editorial guidelines apply to concepts in the International Release; editorial guidelines for concepts in national extensions may vary.
Causative agent type | Allowed | Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.) |
---|
Substance base | yes | Adverse reaction concepts representing a substance base should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example: - 292392003 |Fluphenazine adverse reaction (disorder)|
Expected classification: - Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy.
|
Substance modification | no, unless documented as exception | Adverse reaction concepts representing a substance modification should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Concepts representing substance modifications are exceptions and may be included if the adverse reaction profile is significantly different from the substance base. Exception examples: - Chemical element with multiple modifications (e.g. 422232005 |Calcium lactate gluconate (substance)|)
- Liposome or lipid complex substances (e.g. 412088006 |Amphotericin B liposome (substance)|, 426490000 |Vincristine liposome (substance)|)
- Pegylated substance (e.g. 385544005 |Pegfilgrastim (substance)|, 770965008 |Pegvaliase (substance)|)
- Salt forms (e.g. 412432007 |Metoprolol succinate (substance)|, 72770009 |Metoprolol tartrate (substance)|)
Example: - 292389002 |Fluphenazine decanoate adverse reaction (disorder)|
- 292390006 |Fluphenazine enanthate adverse reaction (disorder)|
Expected classification: - Classification results are expected to reflect that the concept modeled with the modified substance is a descendant of the concept modeled with the base substance (if such a concept exists (e.g. 292389002 |Fluphenazine decanoate adverse reaction (disorder)| has inferred parent 292392003 |Fluphenazine adverse reaction (disorder)|).
|
Multiple substance | yes | Adverse reaction concepts representing multiple substances should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|; preferentially modeling with the base rather than a modification unless the adverse reaction profile is significantly different from the substance base. Example: - 292984002 |Ampicillin and cloxacillin adverse reaction (disorder)|
- 292987009 |Piperacillin and tazobactam adverse reaction (disorder)|
- 292989007 |Ticarcillin and clavulanic acid adverse reaction (disorder)|
Expected classification (Agreed 21-Jan-2020): - Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy.
|
Disposition grouper | yes | Adverse reaction concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example: - 293432006 |3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction (disorder)|
- 870376001 |Adverse reaction to dopamine receptor agonist (disorder)|
Expected classification results: - Classification results are expected to reflect that the adverse reaction concepts are descendants of the appropriate disposition grouper based on the modeling of the 726542003 |Has disposition (attribute)| attribute in the substance hierarchy (e.g. 292113001 |Lansoprazole adverse reaction (disorder)| has inferred parent 292111004 |Proton pump inhibitor adverse reaction (disorder)|).
|
Role grouper | yes | Adverse reaction concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Note that role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. Example: - 430136001 |Adverse reaction caused by antiparkinsonism drug (disorder)|
- 292040004 |Analgesic adverse reaction (disorder)|
Expected classification results (Agreed 21-Jan-2020): - Classification results are expected to reflect that the adverse reaction concepts are descendants of the appropriate disposition grouper based on the modeling of the 726542003 |Has disposition (attribute)| attribute in the substance hierarchy (e.g. 292113001 |Lansoprazole adverse reaction (disorder)| has inferred parent 292111004 |Proton pump inhibitor adverse reaction (disorder)|).
- Classification results are expected to be consistent with the modeling in the Substance hierarchy for concepts modeled with an attribute value from the Substance hierarchy.
|
Structure grouper | yes | Adverse reaction concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example: - 218638005 |Adverse reaction caused by hydantoin derivative (disorder)|
- 419885006 |Beta lactam adverse reaction (disorder)|
Expected classification (Agreed 21-Jan-2020): - Classification results are expected to be consistent with the modeling in the Substance hierarchy and with other existing concepts in the subhierarchy.
|
Descendant of 373873005 |Pharmaceutical / biologic product (product)| | no, unless documented as exception | Exceptions: None identified |
The following types of groupers are out of scope; existing concepts have been inactivated or will be addressed in future release:
...